2002Chinese New Drugs JournalRequires access

Evaluation on the efficacy of batroxobin in the treatment of renal insufficiency patients after acute cerebral infarction

He Wen

Open publisher page 0 citations

Abstract

Objective:To evaluate the efficacy of batroxobin in the treatment of renal insufficiency patients after acute cerebral infarction.Methods:80 patients were randomly divided into treatment group and control group.Besides the routine treatment in all patients,the patients in treatment group were given the batroxobin,d1 10BU,d3 and d5 both 5 BU in 250mL normal saline,iv drip.Two groups were evaluated the curative effect after 15d,and the changes of anticoagulation, plasminogen and serum lipid in two groups before and after treatment were compared.Results:After one course of treatment,there was significant difference in the curative rate (73.8% vs 34.2%, P 0.01) between treatment group and control group.Conclusion:Batroxobin is effective in the treatment of renal insufficiency patients after acute cerebral infarction.

About this research paper

What this paper is about

Objective:To evaluate the efficacy of batroxobin in the treatment of renal insufficiency patients after acute cerebral infarction.Methods:80 patients were randomly divided into treatment group and control group.Besides the routine treatment in all patients,the patients in treatment group were given the batroxobin,d1 10BU,d3 and d5 both 5 BU in 250mL normal saline,iv drip.Two groups were evaluated the curative effect after 15d,and the changes of anticoagulation, plasminogen and serum lipid in two groups before and after treatment were compared.Results:After one course of treatment,there was significant difference in the curative rate (73.8% vs 34.2%, P 0.01) between treatment group and control group.Conclusion:Batroxobin is effective in the treatment of renal insufficiency patients after acute cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the efficacy of batroxobin in the treatment of renal insufficiency patients after acute cerebral infarction.Methods:80 patients were randomly divided into treatment group and control group.Besides the routine treatment in all patients,the patients in treatment group were given the batroxobin,d1 10BU,d3 and d5 both 5 BU in 250mL normal saline,iv drip.Two groups were evaluated the curative effect after 15d,and the changes of anticoagulation, plasminogen and serum lipid in two groups before and after treatment were compared.Results:After one course of treatment,there was significant difference in the curative rate (73.8% vs 34.2%, P 0.01) between treatment group and control group.Conclusion:Batroxobin is effective in the treatment of renal insufficiency patients after acute cerebral infarction.

Key concepts: Batroxobin, Medicine, Cerebral infarction, Treatment and control groups, Internal medicine, Surgery, Gastroenterology, Fibrinogen

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation on the efficacy of batroxobin in the treatment of renal insufficiency patients after acute cerebral infarction — Research Paper | ScholarLens